Direct acting antivirals for the treatment of hepatitis C in ethnic minority populations.

doi:10.1080/14656566.2018.1446945

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Direct acting antivirals for the treatment of hepatitis C in ethnic minority populations.

Expert opinion on pharmacotherapy - 1 Apr 2018

Wilder Julius M, Muir Andrew

Abstract excerpt

INTRODUCTION: Direct acting antivirals (DAA's) have revolutionized the treatment of hepatitis C (HCV). However, questions persist concerning their efficacy in minority populations. AREAS COVERED: In this review, the authors review outcomes for treatment of HCV by race and ethnicity among the clinical trials that have led to the current recommended treatments for HCV. The authors highlight the efficacy and safety...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzimidazoles
Share to Benzofurans
Share to Carbamates
Share to Drug Therapy, Combination
Share to Fluorenes
Share to Hepatitis C
Share to Heterocyclic Compounds, 4 or More Rings
Share to Imidazoles

Source

Open in PubMed

Identifiers

PMID: 29488438
DOI: 10.1080/14656566.2018.1446945

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics